RYTARY Drug Profile, 2024: RYTARY (carbidopa; levodopa) drug patents, FDA exclusivity, litigation, sales revenues (DrugPatentWatch Business Intelligence Reports)
$249.00
Description
RYTARY Drug Profile, 2024: RYTARY (carbidopa; levodopa) drug patents, FDA exclusivity, litigation, sales revenues (DrugPatentWatch Business Intelligence Reports)